Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer
{{output}}
Fibroblast growth factor receptor (FGFR) due to its central role in regulating cell survival, is a promising target for cancer therapeutics. Dysregulation of the FGFR pathway has been observed in several malignancies, including non-small cell lung cancer (NSCL... ...
